MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA (FAVORABLE SUBTYPE)

Clinical trials for MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA (FAVORABLE SUBTYPE) explained in plain language.

Never miss a new study

Get alerted when new MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA (FAVORABLE SUBTYPE) trials appear

Sign up with your email to follow new studies for MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA (FAVORABLE SUBTYPE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New bladder wash could spare patients from major surgery

Disease control Not yet recruiting

This study is testing whether washing the bladder with two chemotherapy drugs, gemcitabine and docetaxel, can control high-risk bladder cancer that has stopped responding to the standard BCG treatment. The goal is to see if this approach can effectively treat the cancer and preve…

Matched conditions: MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA (FAVORABLE SUBTYPE)

Phase: PHASE2 • Sponsor: Michael A. O'Donnell • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA (FAVORABLE SUBTYPE)

Get alerted when new MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA (FAVORABLE SUBTYPE) trials appear

New bladder wash could spare patients from major surgery